Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 541-546

  Anose, Bynthia M ^a   Lagoo, Lisa ^a   Schwendinger, Jamie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FLUTAMIDE; PRASTERONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; ZINC FINGER E BOX BINDING FACTOR; ZINC FINGER PROTEIN; ANTIANDROGEN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

CANCER CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ARTICLE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANDROGEN ANTAGONISTS; DIHYDROTESTOSTERONE; FLUTAMIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 46749094254     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_55     Document Type: Conference Paper

References (8)

1. What are the key statistics about prostate cancer? (2006) American Cancer Society, Inc. Accessed 12 May, 2006. Available at http://www.cancer.org/ docroot/CRI/content/CRI-2-4-1X-What- are-the-key-statistics-for-prostate-cancer- 36.asp?sitearea
2. Hartel A, Didier A, Pfaffl MW, et al. (2003) Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds. J Steroid Biochem Mol Biol 84:231-238.
3. Barry MJ (2001) Prostate specific antigen testing for early diagnosis of prostate cancer. New Engl J Medicine 344:1373-1377.
4. Anose BM, Landry MM, and Sanders MM (2004) Investigating the Role and Regulation of ZEB-1 by Quantitative Real-Time PCR. 12th International Congress of Endocrinology, pp. 1473-1478.
5. Ornstein DK, Rao GS, Johnson B, et al. (1996) Combined finasteride and flutamide therapy in men with advanced prostate cancer. Urology 48:901-905.
6. Stone NN, Clejan SJ (1991) Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia. J Andrology 12:376-380.
7. Airhart RA, Barnett TF, Sullivan JW, et al. (1978) Flutamide therapy for carcinoma of the prostate. S Med J 71:798-801.
8. Taplin ME, Bubley GJ, Shuster TD, et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. New Engl J Med 332:1393-1398.